Radiation Synovectomy with 166Ho-Ferric Hydroxide: A First Experience
Sedat Ofluoglu, MD1,
Eva Schwameis, MD2,
Harald Zehetgruber, MD2,
Ernst Havlik, PhD3,
Axel Wanivenhaus, MD2,
Ingrid Schweeger, MD1,
Konrad Weiss, MD4,
Helmut Sinzinger, MD1 and
Christian Pirich, MD1
1 Department of Nuclear Medicine, University of Vienna, Vienna, Austria
2 Department of Orthopedics, University of Vienna, Vienna, Austria
3 Department of Biomedical Engineering and Physics and Ludwig Boltzmann Institute of Nuclear Medicine, Vienna, Austria
4 Department of Nuclear Medicine, General Hospital of Wiener Neustadt, Wiener Neustadt, Austria

View larger version (78K):
[in a new window]
|
FIGURE 1. Patient 2. (A) Deposition of 166Ho-FH in left knee joint (anterior view) 3 h after intraarticular tracer injection without evidence of leakage. (B) Absence of any leakage 24 h after tracer injection (anterior view).
|
|

View larger version (62K):
[in a new window]
|
FIGURE 2. Patient 5. (A) Deposition of 166Ho-FH in right knee (anterior view) 3 h after intraarticular tracer injection without evidence of leakage. (B) Leakage to inguinal lymph nodes 24 h after tracer injection (anterior view).
|
|
Copyright © 2002 by the Society of Nuclear Medicine.